{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:50:19Z","timestamp":1679881819970},"reference-count":14,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 Graft-versus-leukemia effect is an immune-mediated antitumor phenomenon associated with allogenic bone marrow transplants (BMTs) for hematological malignancies, and recent findings have indicated that a similar effect could occur in some solid tumors such as breast cancers. The authors report on a 42-year-old man with a recurrent ependymoma who received an allogenic BMT for therapy-related leukemia. After transplantation, the patient developed chronic graft-versus-host disease, which was controlled with steroid agents. Interestingly, the recurrent ependymoma regressed steadily over the next 21 months posttransplant, until the tumor became almost undetectable on magnetic resonance images. This case indicates that the graft-versus-tumor effect, mediated by cytotoxic T cells, may be able to target intraparenchymal neuroepithelial tumors, despite the brain's generally recognized status as an immunoprivileged organ.<\/jats:p>","DOI":"10.3171\/jns.2002.97.2.0474","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:45:03Z","timestamp":1242236703000},"page":"474-476","source":"Crossref","is-referenced-by-count":5,"title":["A graft-versus-tumor effect in a patient with ependymoma who received an allogenic bone marrow transplant for therapy-related leukemia"],"prefix":"10.3171","volume":"97","author":[{"given":"Minoru","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Shibui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Cancer Res","first-page":"5797","article-title":"Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.","volume":"60","author":"Anderson","year":"2000"},{"key":"b2","series-title":"Br J Haematol","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2141.1988.tb07628.x","article-title":"Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.","volume":"69","author":"Apperley","year":"1988"},{"key":"b3","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3171\/jns.1989.70.2.0175","article-title":"Intratumoral LAK cell and interleukin-2 therapy of human gliomas.","volume":"70","author":"Barba","year":"1989"},{"key":"b4","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.","volume":"343","author":"Childs","year":"2000"},{"key":"b5","series-title":"Blood","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","article-title":"Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer.","volume":"88","author":"Eibl","year":"1996"},{"key":"b6","series-title":"Blood","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990"},{"key":"b7","series-title":"Biol Blood Marrow Transplant","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/bbmt.1999.v5.pm10392958","article-title":"Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.","volume":"5","author":"Johnson","year":"1999"},{"key":"b8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/jns.1999.90.6.1115","article-title":"Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.","volume":"90","author":"Liau","year":"1999"},{"key":"b9","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3171\/jns.1978.49.1.0084","article-title":"Immune surveillance and tumors of the nervous system.","volume":"49","author":"Morantz","year":"1978"},{"key":"b10","series-title":"Curr Opin Immunol","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0952-7915(93)90064-Y","article-title":"Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments.","volume":"5","author":"Streilein","year":"1993"},{"key":"b11","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3171\/jns.1996.84.2.0258","article-title":"Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme.","volume":"84","author":"Tsurushima","year":"1996"},{"key":"b12","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.","volume":"300","author":"Weiden","year":"1979"},{"key":"b13","series-title":"Brain Res Brain Res Rev","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0165-0173(95)00010-0","article-title":"The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.","volume":"21","author":"Weller","year":"1995"},{"key":"b14","series-title":"Cancer Res","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.","volume":"61","author":"Yu","year":"2001"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/97\/2\/article-p474.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/97\/2\/article-p474.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/97\/2\/article-p474.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T01:18:24Z","timestamp":1679275104000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/97\/2\/article-p474.xml"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":14,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns.2002.97.2.0474","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}